#419S&P 500 rank

NRG — NRG Energy, Inc.

2-yr score: 41.6/100 (Lower 20%)Utilities14d
$99.80+2.00%
Description

NRG Energy, Inc., together with its affiliated entities, operates as a comprehensive power utility spanning the United States. Its operations are divided into three main geographical divisions: Texas, East, and West.

Score breakdownLatest quarter49.1 · Fair
Growth
100.0
Quality / Profitability
54.0
Financial health
44.8
Ratio screener
24.9
Track record: 2-yr avg 41.6 (Weak, 8 quarters ≈ 2 yrs) · long-term avg 42.8 (Weak, 40 quarters ≈ 10 yrs) · next earnings Nov 5, 2026 (in 14 days)
Valuation context (informational only — not part of the score)
Rich vs. its own history
Entry timing (informational only — not part of the score)
Favorable (oversold / below trend)
Live market dataPrice updated Oct 21, 4:26 PM ET
P/E (TTM)
26.3
Yield
1.35%
RSI (14)
43.8
vs SMA20
-1.26%
vs SMA50
-7.63%
vs SMA200
-27.28%
Analyst target
$189
+89.6%
11 analysts
AI theoretical price
$135
+35.3%
as of 2026-09-13

Price chart & technical analysis

Loading chart…

AI deep-dive analysisAnalysis as of 2026-09-13 - price/technical figures below reflect that date, not live market data

As of 2026-09-13, NRG trades at $113.46 — down 25.8% over six months, 22.1% below its 200-day SMA and near the low end of its $108.34–$189.96 52-week range — even as sell-side consensus stays at Buy with a ~$203 average target. The core tension is a trailing P/E of 29.7 against a forward P/E of roughly 12.8 on consensus next-FY EPS of $8.888.

AI sentimentNeutral

The tape and the analyst community are telling opposite stories. Analysts remain constructive (18 Buy, 1 Strong Buy, 7 Hold, 1 Sell; consensus target $202.9 per FMP, with the live brief citing $187–$198) on the AI/data-center power-demand narrative and the August 4, 2026 Q2 print that showed Adjusted EBITDA of $1,217M and $1,025M of FCF before growth investment. But the stock has voted the other way: -4.7% in a week, -6.0% in a month, -25.8% in six months, sitting 22.1% below its 200-day SMA. The trigger was Q2 landing 'mixed relative to aggressive consensus expectations,' compounded by discomfort over a balance sheet that just ballooned (total assets $24.0B → $40.1B, long-term debt $11.2B → $21.7B across Q3 2025–Q1 2026) and net insider selling with no open-market buying. Net: long-term optimism, near-term caution — genuinely mixed.

Quarterly trend

Top-line growth is accelerating on paper but is partly inorganic. Revenue went $6.74B (Q2 2025) → $7.64B (Q3 2025) → $7.75B (Q4 2025) → $10.30B (Q1 2026) → $11.06B (Q2 2026), i.e. +20% YoY in Q1 2026 and +64% YoY in Q2 2026, with H1 2026 at ~$21.4B. That step-change lines up with the balance-sheet transformation (equity +190% in a single quarter, long-term debt up ~$10B, total assets up ~$16B), so a large acquisition/consolidation — not purely organic demand — is driving much of it. Earnings quality is the weak spot: quarterly diluted EPS has swung from -$0.62 (Q2 2025) to $3.61 (Q1 2025) to $2.34 (Q2 2026), and TTM EPS of $4.062 is dragged down by weak Q3 2025 ($0.69), Q4 2025 ($0.26) and Q1 2026 ($0.52). Operating margin is chronically thin and volatile — TTM 5.4%, ranging from 13.2% (Q1 2025) to -11.2% (Q3 2024). This is a lumpy, commodity-exposed merchant-power earnings stream where the most recent quarter ($2.34) is running well above the trailing average, which is exactly what drives the gap between the 29.7x trailing P/E and the ~12.8x forward P/E. Distinguish the blip from the trend carefully: the revenue inflection looks structural (data-center demand plus acquired assets), while the profit trend is unproven and one strong quarter is not yet a trend.

Valuation assessment

NRG is simultaneously expensive and cheap depending on which earnings you use. Trailing: P/E 29.7 vs. its own 5-year average of 16.87 (4 years used), P/S 0.651 vs. 5-year average 0.54, P/B 4.88, EV/EBITDA 11.15 — the deterministic model labels this 'Rich vs. its own history' (score 12.1). Forward: next-FY consensus EPS of $8.888 puts the forward P/E at ~12.8x and PEG at 0.491, below the stock's own historical average multiple. The dividend yield is modest at 1.35%. Verdict: fairly-to-richly valued on trailing numbers that were depressed by lumpy 2025 quarters, and genuinely cheap on forward numbers only if that $8.888 EPS estimate is real. The entire valuation debate reduces to the credibility of the forward estimate.

Price vs. earnings playbook

The market is currently pricing NRG off trailing earnings that were suppressed by a soft Q3 2025 (-$0.62), Q4 2025 ($0.26) and Q1 2026 ($0.52), which mechanically inflates the 29.7x P/E and makes the stock look pricier than the business is running right now. Meanwhile the $113.46 price likely under-prices a forward step-up to ~$8.89 if Q2 2026's $2.34 run-rate holds. So neither side is 'wrong' — they're pricing different years. The playbook: treat the November Q3 2026 print as the referendum. If Q3 EPS lands near $2, the ~12.8x forward multiple is a real discount and the stock is mispriced; if Q3 reverts toward $1 or below, the forward estimate gets cut, the 'cheapness' evaporates and 29x trailing becomes the honest number again. Do not underwrite the forward multiple until Q3 confirms it.

Technical picture

As of 2026-09-13, the technical picture is bearish-but-not-oversold. RSI(14) stood at 44.59 — neutral, with no oversold bounce signal — while price was 1.42% below the 20-day SMA, 9.22% below the 50-day SMA and 22.13% below the 200-day SMA, a clean, persistent downtrend. The stock is within ~5% of its 52-week low of $108.34 and has lost 5.97% in a month, 9.57% in three months and 25.78% in six months. Implication for entry timing: there is no evidence of a bottom yet — no oversold washout, no reclaim of a moving average — so catching the falling knife has poor odds. A more disciplined entry is either a stabilization above the 20/50-day SMAs or an oversold RSI reading below ~30 near the $108 52-week-low support, ideally paired with confirmation from the Q3 earnings print.

Macro factors
  • Secular AI/data-center electricity demand — the dominant tailwind for independent power producers, with NRG's ERCOT (Texas) footprint sitting at the epicenter; the brief cites a 1.2 GW CCGT hyperscaler negotiation.
  • Interest rates and leverage — with ~$21.7B of long-term debt against $4.86B of equity (D/E 4.83x), NRG is highly sensitive to refinancing costs and to the discount rate applied to its cash flows; management is prioritizing debt paydown over buybacks.
  • Commodity and weather volatility — deregulated merchant operations mean earnings swing on natural gas prices, spark spreads and extreme weather; the operating-margin range (13.2% to -11.2%) reflects this.
  • ERCOT market design and regulatory/legislative risk — grid-reliability incentives, capacity-market reforms and environmental/air-compliance frameworks directly affect the economics of new Texas thermal builds.
  • Capital-intensity/capex cycle — funding the Texas Energy Fund projects and new-build generation absorbs cash, contributing to lumpy free cash flow (negative $486M in Q1 2026, negative $175M in Q4 2025).
Key catalysts
  • Q3 2026 earnings (typically early-to-mid November 2026) — the key test of whether the ~$8.89 next-FY EPS estimate and reaffirmed full-year guidance are credible.
  • Conversion of the 1.2 GW hyperscaler combined-cycle data-center project in Texas into a signed contract — a potential step-change in contracted cash flow.
  • Texas Energy Fund new-build projects reaching commercial operation (T.H. Wharton's 415 MW is already online) on time and on budget.
  • Debt-paydown progress and any credit-rating/leverage-ratio improvement that would relieve the balance-sheet discount.
  • ERCOT market-design and reliability-pricing decisions that could enhance margins on new thermal generation.
Key risks
  • Balance-sheet leverage: long-term debt of $21.74B vs. $4.86B of equity (D/E 4.83x; LT debt/equity 4.48x) and a current ratio of 0.968 — a genuine solvency-adjacent risk if commodity or power markets turn.
  • Earnings/free-cash-flow lumpiness: negative FCF in Q1 2026 (-$486M) and Q4 2025 (-$175M), and an operating-margin range spanning 13.2% to -11.2% in recent quarters.
  • Forward-estimate risk: the ~12.8x forward P/E depends entirely on $8.888 next-FY EPS, a number well above the $4.062 TTM figure; a single weak quarter could invalidate it and re-rate the stock back to ~29x trailing.
  • Trailing valuation vs. own history: P/E 29.7 vs. 5-year average 16.87 and P/S 0.651 vs. 0.54, leaving little cushion if growth stalls.
  • Insider signal: net selling over the trailing 12 months with no notable open-market buying, and an analyst consensus that may lag the deteriorating price action.
Investment thesis

NRG is a real AI-power-demand story with a structurally accelerating top line and a forward P/E (~12.8x) that looks cheap if the ~$8.89 next-FY EPS materializes — but the thesis rests on an unproven earnings step-up, a balance sheet now carrying 4.8x debt/equity, and two negative-FCF quarters in the last four. With the stock 22% below its 200-day SMA and RSI at 44.6 (not oversold), this is a 'prove-it' situation rather than a clean buy, and the risk/reward favors patience over buying today. My lean is Neutral: interesting, but not yet de-risked.

AI theoretical price methodology

Built from a forward P/E anchor: applying ~15.3x to next-FY consensus EPS of $8.888 gives ~$136, a multiple modestly below NRG's own 16.87x five-year average to reflect its 4.8x debt/equity and commodity exposure. Cross-checked with an EV/EBITDA approach — ~10.5x on roughly $4.6B of forward EBITDA less ~$21.6B net debt, divided by ~211M shares — which yields ~$126; blending the two methods lands at ~$135, implying ~19% upside from the 2026-09-13 price of $113.46 but far below the sell-side consensus of ~$203.

AI lean: NeutralConfidence: Low
AI review of the deterministic score
Partially Agree

The 49.1 'Fair Fundamentals' band is a defensible middle, but I'd nudge it up roughly 10 points toward the high-50s (still Fair, borderline Good) because the fixed formula is structurally blind to two things here. First, it scores growth on trailing YoY (100/100 on strong revenue/OCF) while the ratio screener (24.9) and 'Rich vs. own history' context penalize trailing multiples — yet the 29.7x trailing P/E is inflated by unusually weak 2025 quarters, whereas the forward P/E on the $8.888 next-FY consensus is only ~12.8x, below the stock's own 16.9x five-year average. Second, the balance-sheet step-change (total assets $24.0B → $40.1B, LT debt $11.2B → $21.7B, equity +190% in one quarter, flagged in the score's own notes) distorts both the growth and leverage legs, cutting both ways. The leverage, negative FCF in two of four quarters and volatile margins keep me from endorsing anything above Fair — so I'd move the score but keep the band roughly intact.

AI-generated analysis for informational purposes only, not financial advice.